Hitinder Gurm, M.D., named next chief clinical officer for UH/CVC
Hitinder Gurm, M.D. will serve as the new chief clinical officer for the University Hospital and Frankel Cardiovascular Center (UH/CVC) segment of Michigan Medicine, effective June 1.
The announcement yesterday from David C. Miller, M.D., M.P.H., president of the U-M Health System and executive vice dean for clinical affairs, indicated that in his new role, Gurm will provide clinical operational leadership related to all clinical processes, systems, people and practices, focusing on improving safety, quality, timeliness and financial stewardship.
Since 2017, Gurm has served as the associate chief clinical officer for the CV/Neuro sub-segment of the UH/CVC segment, which provides adult inpatient services and is one of the three major segments of the clinical enterprise.
A professor of internal medicine in the division of cardiovascular medicine, Gurm obtained his cardiology training at the Cleveland Clinic and joined U-M in 2005 as an interventional cardiologist. He leads the Blue Cross Blue Shield Cardiovascular Consortium (BMC2), a multi-center, quality improvement registry funded by Blue Cross Blue Shield of Michigan. The consortium focuses on improving the quality of care and outcomes for patients who undergo cardiovascular procedures in the state of Michigan.
Gurm has published more than 250 original articles and book chapters, and has been named as an inventor on five patents.
He was the recipient of the Michigan Health & Hospital Association’s Patient Safety & Quality Leadership Award in 2016 and has been elected to the American Society for Clinical Investigation (ASCI).